Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma

Oncology Reports

Volumn 29, Issue 1, 2013, Pages 169-176

  Yang, Miao ^a   Liu, Ran ^a   Sheng, Jingyi ^a   Liao, Juan ^a   Wang, Yi ^b   Pan, Enchun ^b   Guo, Wei ^c   Pu, Yuepu ^a   Yin, Lihong ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b Huaian Center for Disease Control and Prevention   (China)

^c THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Esophageal carcinoma; Microarray; MicroRNA; Profile

Indexed keywords

MICRORNA; MICRORNA 139 5P; MICRORNA 183; MICRORNA 21; MICRORNA 218; MICRORNA 338 3P; MICRORNA 574 5P; MICRORNA 601; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; CASE REPORT; DISEASE ASSOCIATION; DOWN REGULATION; DRINKING; EARLY DIAGNOSIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; EARLY DIAGNOSIS; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84872870630     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2105     Document Type: Article

References (52)

1. Jinyi Z, Quanyong X, Ran T, Jie Y, Ping L and Ming W: Analysis on surveillance of cause death in Jiangsu province during 2007. Jiangsu J Prev Med 2008 19: 74-75, 2008.
2. Rice TW, Rusch VW, Apperson-Hansen C, et al: Worldwide esophageal cancer collaboration. Dis Esophagus 22: 1-8, 2009.
3. Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006.
4. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
5. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
6. Manikandan J, Aarthi JJ, Kumar SD and Pushparaj PN: Oncomirs: the potential role of non-coding microRNAs in understanding cancer. Bioinformation 2: 330-334, 2008.
7. Schetter AJ, Heegaard NHH and Harris CC: Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 31: 37-49, 2010.
8. Kwak PB, Iwasaki S and Tomari Y: The microRNA pathway and cancer. Cancer Sci 101: 2309-2315, 2010.
9. Ahmed FE: Role of miRNA in carcinogenesis and biomarker selection: a methodological view. Expert Rev Mol Diagn 7: 569-603, 2007.
10. Kan T and Meltzer SJ: MicroRNAs in Barrett's esophagus and esophageal adenocarcinoma. Curr Opin Pharmacol 9: 727-732, 2009.
11. Yang HS, Gu J, Wang KK, et al: MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res 15: 5744-5752, 2009.
12. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 25: 402-408, 2001.
13. Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269, 2006.
14. Chen X, Hu ZB, Wang WJ, et al: Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Int J Cancer 130: 1620-1628, 2012.
15. Hu YX, Correa AM, Hoque A, et al: Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int J Cancer 128: 132-143, 2011.
16. Wiggins JF, Ruffino L, Kelnar K, et al: Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res 70: 5923-5930, 2010.
17. Guo Y, Chen Z, Zhang L, et al: Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 68: 26-33, 2008.
18. Ogawa R, Ishiguro H, Kuwabara Y, et al: Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med Mol Morphol 42: 102-109, 2009.
19. Feber A, Xi L, Luketich JD, et al: MicroRNA expression profiles of esophageal cancer. J Thorac Cardiovasc Surg 135: 255-260, 2008.
20. Guo J, Miao Y, Xiao B, et al: Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 24: 652-657, 2009.
21. Fridman E, Dotan Z, Barshack I, et al: Accurate molecular classification of renal tumors using microRNA expression. J Mol Diagn 12: 687-696, 2010.
22. Hiroki E, Akahira J, Suzuki F, et al: Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas. Cancer Sci 101: 241-249, 2010.
23. Yoshino H, Chiyomaru T, Enokida H, et al: The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Br J Cancer 104: 808-818, 2011.
24. Miles GD, Seiler M, Rodriguez L, Rajagopal G and Bhanot G: Identifying microRNA/mRNA dysregulations in ovarian cancer. BMC Res Notes 5: 164, 2012.
25. Au SL, Wong CC, Lee JM, et al: Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis. Hepatology 56: 622-631, 2012.
26. Yu JJ, Wang Y, Dong RF, Huang XY, Ding SN and Qiu HF: Circulating microRNA-218 was reduced in cervical cancer and correlated with tumor invasion. J Cancer Res Clin Oncol 138: 671-674, 2012.
27. Tatarano S, Chiyomaru T, Kawakami K, et al: miR-218 on the genomic loss region of chromosome 4p15. 31 functions as a tumor suppressor in bladder cancer. Int J Oncol 39: 13-21, 2011.
28. Gao CP, Zhang ZY, Liu WZ, Xiao SD, Gu WQ and Lu H: Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer 116: 41-49, 2010.
29. Huang XH, Chen JS, Wang Q, et al: miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened. J Pathol 225: 463-472, 2011.
30. Yu J, Li A, Hong SM, Hruban RH and Goggins M: MicroRNA alterations of pancreatic intraepithelial neoplasias. Clin Cancer Res 18: 981-992, 2012.
31. Foss KM, Sima C, Ugolini D, Neri M, Allen KE and Weiss GJ: miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol 6: 482-488, 2011.
32. Yao Y, Suo AL, Li ZF, et al: MicroRNA profiling of human gastric cancer. Mol Med Rep 2: 963-970, 2009.
33. Ohdaira H, Nakagawa H and Yoshida K: Profiling of molecular pathways regulated by microRNA 601. Comput Biol Chem 33: 429-433, 2009.
34. Lowery AJ, Miller N, Dwyer RM and Kerin MJ: Dysregulated miR-183 inhibits migration in breast cancer cells. BMC Cancer 10: 502, 2010.
35. Schaefer A, Jung M, Mollenkopf HJ, et al: Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer 126: 1166-1176, 2010.
36. Li J, Fu H, Xu C, et al: miR-183 inhibits TGF-beta1-induced apoptosis by downregulation of PDCD4 expression in human hepatocellular carcinoma cells. BMC Cancer 10: 354, 2010.
37. Bandres E, Cubedo E, Agirre X, et al: Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5: 29, 2006.
38. Sarver AL, Li LH and Subramanian S: MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res 70: 9570-9580, 2010.
39. Li GR, Luna C, Qiu JM, Epstein DL and Gonzalez P: Targeting of integrin beta1 and kinesin 2alpha by microRNA 183. J Biol Chem 285: 5461-5471, 2010.
40. Kanasaki K, Kanda Y, Palmsten K, et al: Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus. Dev Biol 313: 584-593, 2008.
41. Wederell ED and de Iongh RU: Extracellular matrix and integrin signaling in lens development and cataract. Semin Cell Dev Biol 17: 759-776, 2006.
42. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV and Mendell JT: c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435: 839-843, 2005.
43. Iorio MV, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005.
44. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006.
45. Greither T, Grochola LF, Udelnow A, Lautenschlager C, Wurl P and Taubert H: Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int J Cancer 126: 73-80, 2010.
46. Jiang SA, Zhang HW, Lu MH, et al: MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 70: 3119-3127, 2010.
47. Wang G, Chan ES, Kwan BC, et al: Expression of microRNAs in the urine of patients with bladder cancer. Clin Genitourin Cancer 10: 106-113, 2012.
48. Chiang YP, Song YX, Wang ZN, et al: microRNA-192,-194 and-215 are frequently downregulated in colorectal cancer. Exp Ther Med 3: 560-566, 2012.
49. Rossing M, Borup R, Henao R, et al: Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma. J Mol Endocrinol 48: 11-23, 2012.
50. Wang LL, Zhang ZF, Li Q, et al: Ethanol exposure induces differential microRNA and target gene expression and teratogenic effects which can be suppressed by folic acid supplementation. Hum Reprod 24: 562-579, 2009.
51. Soares AR, Pereira PM, Ferreira V, et al: Ethanol exposure induces upregulation of specific microRNAs in zebrafish embryos. Toxicol Sci 127: 18-28, 2012.
52. Miranda RC, Pietrzykowski AZ, Tang Y, et al: MicroRNAs: master regulators of ethanol abuse and toxicity? Alcohol Clin Exp Res 34: 575-587, 2010.